Expand COGT Menu
COGT MENU

COGT Latest Press Releases

-- December 8, 2025 --

Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) Globe Newswire 7:30 AM

-- December 6, 2025 --

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH) Globe Newswire 9:30 AM

-- November 14, 2025 --

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- November 11, 2025 --

Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031 Globe Newswire 11:16 PM

-- November 10, 2025 --

Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock Globe Newswire 4:01 PM
Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST) Globe Newswire 7:00 AM

-- November 3, 2025 --

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results Globe Newswire 9:01 AM
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting Globe Newswire 9:00 AM

-- October 24, 2025 --

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Globe Newswire 12:30 PM

-- October 20, 2025 --

Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib Globe Newswire 8:32 AM

-- September 29, 2025 --

Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 26, 2025 --

Cogent Biosciences Announces Participation in the Citi Biopharma Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes